Moshe Ornstein

18PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChiropracticMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 09, 2025
From Challenges to Cures: Improving Outcomes in Patients With Renal Cell Carcinoma.

Moshe C Ornstein

|Jan 04, 2025
Medical Professionals' Perceptions of and Experiences With Terminally Ill Orthodox Jewish Patients.

Moshe C Ornstein, David Harris

|Aug 20, 2024
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment.

Moshe C Ornstein, Lisa C Rosenblatt, Xin Yin

|Apr 11, 2024
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).

Michael B Atkins, Opeyemi A Jegede, Naomi B Haas

|Jul 04, 2023
Targeting HIF-2 Alpha in Renal Cell Carcinoma.

Ramsha Ahmed, Moshe C Ornstein

|Mar 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).

Michael B Atkins, Opeyemi A Jegede, Naomi B Haas

Pageof 3

Frequent Collaborators

3 joint publications

Landon C Brown

3 joint publications

Michael B Atkins

2 joint publications

Tian Zhang

2 joint publications

David Einstein